Phase 4 Primary Biliary Cholangitis Trial, Recruiting NCT04650243 Sponsor: Peking Union Medical College Hospital Condition: Primary Biliary Cholangitis
Back to Primary Biliary Cholangitis

Phase 4 Primary Biliary Cholangitis Trial, Recruiting

NCT04650243
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Primary Biliary Cholangitis (PBC) based on recognised medical guidelines
  • You are 18 years old or older
  • Your PBC is at stage 2 or 3, meaning your liver function tests are abnormal and you are experiencing symptoms
  • After 6 to 12 months of treatment with a medication called UDCA, certain liver test results (ALP and AST) have improved to near-normal levels and your bilirubin level is normal
  • You are willing and able to give your informed consent to take part

Who may not be able to join:

  • You have another liver condition at the same time, such as Hepatitis B, Hepatitis C, or alcohol-related liver disease, or certain liver enzyme levels (ALT or AST) are more than twice the normal range
  • Your liver is no longer functioning well enough to keep you stable (known as decompensated liver disease, classified as Child grade B or C) (confirm with trial site)
  • You have a serious problem with another major organ (such as kidney failure), a significant infection, or other serious health complications
  • You are pregnant, planning to become pregnant, or currently breastfeeding, or you have a psychiatric condition
  • You are currently taking part in another clinical trial, or you have taken part in one within the last three months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Li Wang, Peking Union Medical College Hospital

Phone: 8613801175089

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
21 January 2020
Est. completion
1 May 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Recurrence rate of primary biliary cholangitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov